Product image of Ifirmasta (Irbesartan) supplied by GNH India

Ifirmasta

Active Ingredient:
Irbesartan
Origin:
EU

Ifirmasta (Irbesartan)

Irbesartan, the active ingredient in Ifirmasta, is an angiotensin II receptor blocker presented as an oral tablet for oral use. It lowers blood pressure and protects kidney function in patients with hypertension and diabetic nephropathy. It works by selectively blocking the AT1 receptor, reducing vasoconstriction and aldosterone release, which contributes to its antihypertensive effect.

GNH India supplies Ifirmasta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution across multiple regions.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ifirmasta (irbesartan) is indicated for conditions involving the renin‑angiotensin system, primarily hypertension and diabetic kidney disease.

  • Hypertension: reduces systolic and diastolic blood pressure, helping to prevent cardiovascular events.
  • Diabetic nephropathy: slows progression of renal impairment in patients with type 2 diabetes.
  • Chronic kidney disease associated with hypertension: helps control blood pressure and reduce proteinuria in CKD patients.

How It Works

  • Irbesartan selectively antagonizes the angiotensin II type 1 (AT1) receptor located on vascular smooth‑muscle cells, adrenal glands and renal tubular cells. By blocking this receptor, it prevents angiotensin II‑mediated vasoconstriction, aldosterone secretion, and sodium‑water retention, leading to vasodilation, reduced blood volume and lowered systemic blood pressure. It also improves endothelial function and reduces inflammatory signaling.

Side Effects

Irbesartan may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Dizziness: light‑headedness especially after standing.
  • Headache: mild to moderate intensity.
  • Fatigue: general tiredness.
  • Nasal congestion: stuffy nose.
  • Elevated serum potassium: mild hyperkalaemia.
  • Diarrhoea: loose stools.
  • Cough: mild throat irritation.
  • Back pain: occasional musculoskeletal discomfort.

Serious or Rare Side Effects

  • Angioedema: swelling of face, lips, tongue or airway.
  • Severe hyperkalaemia: markedly high potassium levels.
  • Acute kidney injury: sudden decline in renal function.
  • Hepatic dysfunction: abnormal liver enzymes.
  • Hypotension: excessive drop in blood pressure.

Precautions & Warnings

When prescribing Irbesartan, clinicians should consider several precautionary measures to ensure safe use.

  • Pregnancy: contraindicated in the second and third trimesters due to fetal toxicity.
  • Renal impairment: monitor kidney function and adjust dose in patients with reduced creatinine clearance.
  • Hyperkalaemia risk: check serum potassium before initiation and periodically during therapy.
  • Concomitant potassium‑sparing diuretics: avoid or use with caution to prevent excess potassium.
  • Volume depletion: assess for dehydration before starting treatment.
  • Store at ambient temperature: keep tablets in the original container, protect from moisture and light.

Avoid Interactions

Irbesartan can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid)

  • Aliskiren (in diabetic patients): combined use may increase risk of renal impairment, hyperkalaemia and hypotension.
  • Potassium supplements or potassium‑sparing diuretics: may cause dangerous hyperkalaemia.
  • ACE inhibitors: concurrent use can lead to additive effects on potassium and renal function.

Moderate Interactions (Monitor Closely)

  • NSAIDs: may reduce antihypertensive effect and worsen renal function.
  • Lithium: may increase lithium levels, requiring serum monitoring.
  • Thiazide diuretics: can enhance antihypertensive effect and increase risk of low blood pressure.
  • Antidiabetic drugs: may need dose adjustment as blood pressure control can affect glucose metabolism.

Frequently Asked Questions

Ifirmasta contains irbesartan, an angiotensin II receptor blocker that is prescribed to lower high blood pressure and to slow the progression of kidney damage in patients with diabetic nephropathy. It is part of standard therapy for hypertension and for protecting renal function in diabetes‑related kidney disease.

Irbesartan selectively blocks the AT1 subtype of the angiotensin II receptor on blood vessels, adrenal glands and kidney cells. This inhibition prevents angiotensin II‑induced vasoconstriction, aldosterone release and sodium retention, resulting in vessel relaxation, reduced blood volume and lower systemic blood pressure.

The appropriate dose of Ifirmasta is determined by the prescribing clinician based on the individual’s blood pressure, kidney function and overall health status. Physicians typically start with a low dose and may adjust it according to therapeutic response and tolerability, following local prescribing guidelines.

Irbesartan is classified as pregnancy category D, indicating evidence of fetal risk, especially in the second and third trimesters. It should be avoided during pregnancy. Limited data are available for breastfeeding, and the drug may pass into breast milk, so use is generally not recommended without careful medical supervision.

To request Ifirmasta, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ifirmasta (irbesartan) belongs to the ARB class, offering similar blood‑pressure‑lowering efficacy to other ARBs such as losartan or valsartan, but with a lower incidence of cough compared with ACE inhibitors. Its selective AT1 blockade provides effective hypertension control while generally being well tolerated.

Ifirmasta tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and avoid storing in areas with high humidity or direct sunlight.

Ifirmasta is taken orally, usually once daily, with or without food, as directed by a healthcare professional. Swallow the tablet whole with a glass of water; do not crush or split the tablet unless specifically instructed by the prescriber.

Serious risks include angioedema (swelling of the face, lips, tongue or airway), severe hyperkalaemia (dangerously high potassium levels), and acute kidney injury. Patients should seek immediate medical attention if they experience swelling, rapid weight gain, reduced urine output, or symptoms of high potassium such as muscle weakness.

Ifirmasta should be avoided in patients with known hypersensitivity to irbesartan or any ARB, in pregnant women beyond the first trimester, and in individuals with severe renal impairment or uncontrolled hyperkalaemia. Caution is also advised for patients on concurrent potassium‑sparing diuretics or aliskiren in diabetes.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Irbesartan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT